Latest News about GSK plc
Recent news which mentions GSK plc
Trump's drug price ultimatum sets pharma firms scrambling
August 01, 2025
From CNBC.com News
From CNBC.com News
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
June 18, 2025
From CNBC.com News
Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
June 17, 2025
From CNBC.com News
FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca
June 09, 2025
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
May 15, 2025
From CNBC.com News
Healthy Returns: Here are the drugmakers with new U.S. investments as Trump’s pharma tariffs loom
April 30, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
From CNBC.com News
From CNBC.com News
Vaccine stocks fall as Senate panel advances RFK Jr.'s nomination for HHS secretary
February 04, 2025
From CNBC.com News
From CNBC.com News
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
January 17, 2025
From CNBC.com News
From CNBC.com News
From CNBC.com News
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
From CNBC.com News
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
October 17, 2024
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
September 24, 2024
From CNBC.com News
Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future
September 12, 2024
From CNBC.com News
Moderna beats estimates but slashes guidance on low EU sales, competitive U.S. vaccine market
August 01, 2024
From CNBC.com News
Pfizer struggles to claw back faith with Wall Street and its employees as it recovers from the Covid decline
June 28, 2024
From CNBC.com News
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections
June 17, 2024
From CNBC.com News
FDA approves GSK's RSV vaccine for high-risk adults ages 50 to 59, expanding shot's reach
June 07, 2024
From CNBC.com News
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
June 03, 2024
From CNBC.com News
From CNBC.com News
From CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
From CNBC.com News
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.